These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36210266)

  • 1. Exercise MR-proANP unmasks latent right heart failure in CTEPH.
    Kriechbaum SD; Birmes J; Wiedenroth CB; Adameit MSD; Gruen D; Vietheer J; Richter MJ; Guth S; Roller FC; Rademann M; Fischer-Rasokat U; Rolf A; Liebetrau C; Hamm CW; Keller T; Rieth AJ
    J Heart Lung Transplant; 2022 Dec; 41(12):1819-1830. PubMed ID: 36210266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.
    Kriechbaum SD; Scherwitz L; Wiedenroth CB; Rudolph F; Wolter JS; Haas M; Fischer-Rasokat U; Rolf A; Hamm CW; Mayer E; Guth S; Keller T; Konstantinides SV; Lankeit M; Liebetrau C
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 7. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV; Truong QA; Gaggin HK; Pfannkuche J; Hartmann O; Januzzi JL
    Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy - a cardiac magnetic resonance imaging cohort study.
    Kriechbaum SD; Vietheer JM; Wiedenroth CB; Rudolph F; Barde M; Wolter JS; Haas M; Fischer-Rasokat U; Weferling M; Rolf A; Hamm CW; Mayer E; Guth S; Keller T; Roller FC; Liebetrau C
    Pulm Circ; 2021; 11(4):20458940211056500. PubMed ID: 34917333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure.
    Gohar A; Rutten FH; den Ruijter H; Kelder JC; von Haehling S; Anker SD; Möckel M; Hoes AW
    Eur J Heart Fail; 2019 Oct; 21(10):1219-1227. PubMed ID: 31209992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-regional pro-atrial natriuretic peptide levels before and after hemodialysis predict long-term prognosis.
    Hasselbalch RB; Kristensen JH; Nielsen TL; Plesner LL; Rydahl C; Schou M; Goetze JP; Bundgaard H; Iversen KK
    Clin Biochem; 2021 Aug; 94():20-26. PubMed ID: 33865815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
    Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
    Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia.
    Nigro N; Winzeler B; Suter-Widmer I; Schuetz P; Arici B; Bally M; Blum CA; Nickel CH; Bingisser R; Bock A; Rentsch Savoca K; Huber A; Müller B; Christ-Crain M
    J Intern Med; 2015 Jul; 278(1):29-37. PubMed ID: 25418365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: effect of gender and pubertal stage.
    Goharian TS; Gimsing AN; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL
    Blood Press; 2015; 24(6):347-52. PubMed ID: 25968593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High levels of atrial natriuretic peptide and copeptin and mortality risk].
    Rey C; García-Cendón C; Martínez-Camblor P; López-Herce J; Concha-Torre A; Medina A; Vivanco-Allende A; Mayordomo-Colunga J
    An Pediatr (Barc); 2016 Dec; 85(6):284-290. PubMed ID: 26988235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
    Daniels LB; Clopton P; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Anand IS; Wu AH; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Filippatos GS; Di Somma S; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
    Eur J Heart Fail; 2012 Jan; 14(1):22-31. PubMed ID: 22140234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.